Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02642224 · ClinicalTrials.gov registry record · NA

Trauma Services Intervention to Prevent Violence

A NA study of Skin Injury Due to Violence and Gunshot Wound, Contact, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
111
Enrollment target
1
Study location

NCT02642224: Completed NA study of Skin Injury Due to Violence and Gunshot Wound, Contact, sponsored by University of Pittsburgh.

NCT02642224 is a NA study of Skin Injury Due to Violence and Gunshot Wound, Contact that has completed, run by University of Pittsburgh. The registered enrollment target is 111 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02642224, a NA study of Skin Injury Due to Violence and Gunshot Wound, Contact, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
111 participants
Enrollment target
1
Study location

Study Summary

Primary outcome: Research participants and their network contacts will be followed over 6 months to assess whether a social work case management protocol results in reduction of trauma services recidivism and criminal violence arrests.

Primary Outcome

Readmission to hospital trauma service because of firearm injury

Interventions

  • BEHAVIORAL Social Work Case Management

Study Locations (1)

Pennsylvania

  • University of Pittsburgh, Graduate School of Public Health - Pittsburgh

Trial Details

FieldValue
Enrollment Target 111 participants
Start Date 2014-05
Est. Completion 2018-05
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT02642224 record still lists

NCT02642224 is an interventional study that assigns participants to a tested intervention. The registered 111 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 2 conditions, with Skin Injury Due to Violence appearing as the primary indexed condition, and to 1 intervention - of which Social Work Case Management is the first listed.

NCT02642224 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02642224 about?

NCT02642224 is a clinical study titled "Trauma Services Intervention to Prevent Violence". Primary outcome: Research participants and their network contacts will be followed over 6 months to assess whether a social work case management protocol results in reduction of trauma services recidivism and criminal violence arrests.

What is the current status of trial NCT02642224?

This trial is currently completed. It is a NA study. The enrollment target is 111 participants. The study started on 2014-05. Estimated completion is 2018-05.

What conditions does trial NCT02642224 study?

This clinical trial studies the following conditions: Skin Injury Due to Violence, Gunshot Wound, Contact.

What interventions are being tested in trial NCT02642224?

The interventions under investigation include: Social Work Case Management (BEHAVIORAL).

Who is sponsoring clinical trial NCT02642224?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02642224 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT02642224's enrollment target sits among peer trials

111 816th of 2000 higher than 1,185 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03875716 · 111 participants · NA

    Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma

  • NCT04693468 · 111 participants · Phase 1

    Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial

  • NCT05263050 · 111 participants · Phase 2

    Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

  • NCT05600842 · 111 participants

    De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02642224, the US trial registry maintained by the National Library of Medicine. NCT02642224 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.